SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000919574-17-002018
Filing Date
2017-02-14
Accepted
2017-02-14 16:36:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 d7410418_13g-a.htm SC 13G/A 109747
  Complete submission text file 0000919574-17-002018.txt   111564
Mailing Address 152 WEST 57TH STREET 50TH FLOOR NEW YORK NY 10019
Business Address 157 WEST 57TH STREET 50TH FLOOR NEW YORK NY 10019 212-333-0100
KINGDON CAPITAL MANAGEMENT, L.L.C. (Filed by) CIK: 0001000097 (see all company filings)

IRS No.: 134015739 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 14 WALL ST. SUITE 3D NEW YORK NY 10005
Business Address 14 WALL ST. SUITE 3D NEW YORK NY 10005 212-269-2834
Dipexium Pharmaceuticals, Inc. (Subject) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88072 | Film No.: 17609559
SIC: 2834 Pharmaceutical Preparations